Canary Speech and Intermountain Ventures Launch Groundbreaking Study to Identify Multiple Sclerosis Using Vocal Biomarkers

Revolutionary AI-driven technology aims to transform MS diagnosis and improve patient outcomes with early detection PROVO, Utah, Feb. 10, 2026 /PRNewswire/ — Canary Speech, a leader in vocal biomarker technology, today announced a partnership with Intermountain Ventures, the venture…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks